Published in J Biol Eng on February 06, 2017
The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science (2002) 49.51
Alzheimer's disease: the amyloid cascade hypothesis. Science (1992) 13.80
Renal clearance of quantum dots. Nat Biotechnol (2007) 12.54
Natural oligomers of the amyloid-beta protein specifically disrupt cognitive function. Nat Neurosci (2004) 9.73
Natural oligomers of the Alzheimer amyloid-beta protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor-dependent signaling pathway. J Neurosci (2007) 8.27
Radiative decay engineering 5: metal-enhanced fluorescence and plasmon emission. Anal Biochem (2005) 5.36
Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red. Proc Natl Acad Sci U S A (1994) 4.33
In vitro characterization of conditions for amyloid-beta peptide oligomerization and fibrillogenesis. J Biol Chem (2002) 4.20
Gold nanoparticles in biology: beyond toxicity to cellular imaging. Acc Chem Res (2008) 3.94
Solution conformations and aggregational properties of synthetic amyloid beta-peptides of Alzheimer's disease. Analysis of circular dichroism spectra. J Mol Biol (1992) 3.53
Aggregation and secondary structure of synthetic amyloid beta A4 peptides of Alzheimer's disease. J Mol Biol (1991) 3.33
Nucleation of protein fibrillation by nanoparticles. Proc Natl Acad Sci U S A (2007) 3.23
Alzheimer's amyloid fibrils: structure and assembly. Biochim Biophys Acta (2000) 3.20
Globular amyloid beta-peptide oligomer - a homogenous and stable neuropathological protein in Alzheimer's disease. J Neurochem (2005) 3.06
Multifunctional magnetic nanoparticles: design, synthesis, and biomedical applications. Acc Chem Res (2009) 3.04
The role of cerebral amyloid beta accumulation in common forms of Alzheimer disease. J Clin Invest (2005) 2.51
Cellular uptake and cytotoxicity of gold nanorods: molecular origin of cytotoxicity and surface effects. Small (2009) 2.40
pH-dependent structural transitions of Alzheimer amyloid peptides. Biophys J (1991) 2.33
High sensitivity analysis of amyloid-beta peptide composition in amyloid deposits from human and PS2APP mouse brain. Neuroscience (2006) 2.03
Amyloid-beta aggregation: selective inhibition of aggregation in mixtures of amyloid with different chain lengths. Biophys J (1994) 1.99
The thioflavin T fluorescence assay for amyloid fibril detection can be biased by the presence of exogenous compounds. FEBS J (2009) 1.72
Nanoparticles in cellular drug delivery. Bioorg Med Chem (2009) 1.70
Inhibition of amyloid beta protein fibrillation by polymeric nanoparticles. J Am Chem Soc (2008) 1.60
Nanotechnology in medical imaging: probe design and applications. Arterioscler Thromb Vasc Biol (2008) 1.55
Physical, morphological and functional differences between ph 5.8 and 7.4 aggregates of the Alzheimer's amyloid peptide Abeta. J Mol Biol (1996) 1.45
Effect of different salt ions on the propensity of aggregation and on the structure of Alzheimer's abeta(1-40) amyloid fibrils. J Mol Biol (2007) 1.39
Impairment of hippocampal long-term potentiation by Alzheimer amyloid beta-peptides. J Neurosci Res (2000) 1.28
Nanoparticles enhance brain delivery of blood-brain barrier-impermeable probes for in vivo optical and magnetic resonance imaging. Proc Natl Acad Sci U S A (2011) 1.21
Physiochemical characterization of the Alzheimer's disease-related peptides A beta 1-42Arctic and A beta 1-42wt. FEBS J (2006) 1.14
Dual effect of amino modified polystyrene nanoparticles on amyloid β protein fibrillation. ACS Chem Neurosci (2010) 1.14
The gold standard: gold nanoparticle libraries to understand the nano-bio interface. Acc Chem Res (2012) 1.07
Inhibition of amyloid peptide fibrillation by inorganic nanoparticles: functional similarities with proteins. Angew Chem Int Ed Engl (2011) 1.06
TiO2 nanoparticles promote beta-amyloid fibrillation in vitro. Biochem Biophys Res Commun (2008) 1.03
Toxicity of gold-nanoparticles: synergistic effects of shape and surface functionalization on micromotility of epithelial cells. Nanotoxicology (2010) 1.02
Acceleration of amyloid beta-peptide aggregation by physiological concentrations of calcium. J Biol Chem (2006) 1.02
Protein fibrillation and nanoparticle interactions: opportunities and challenges. Nanoscale (2013) 1.00
Influence of fluorinated and hydrogenated nanoparticles on the structure and fibrillogenesis of amyloid beta-peptide. Biophys Chem (2008) 0.98
Negatively charged gold nanoparticles inhibit Alzheimer's amyloid-β fibrillization, induce fibril dissociation, and mitigate neurotoxicity. Small (2012) 0.95
Acidic pH promotes the formation of toxic fibrils from beta-amyloid peptide. Brain Res (2001) 0.95
Beta amyloid aggregation inhibitors: small molecules as candidate drugs for therapy of Alzheimer's disease. Curr Med Chem (2010) 0.94
Influence of hydrophobic Teflon particles on the structure of amyloid beta-peptide. Biomacromolecules (2003) 0.91
Effect of nanoparticles on protein folding and fibrillogenesis. Int J Mol Sci (2009) 0.90
25th anniversary article: interfacing nanoparticles and biology: new strategies for biomedicine. Adv Mater (2013) 0.90
Entering the era of nanoscience: time to be so small. J Biomed Nanotechnol (2013) 0.89
The effect of nanoparticles on amyloid aggregation depends on the protein stability and intrinsic aggregation rate. Langmuir (2012) 0.88
Nanoparticles in relation to peptide and protein aggregation. Int J Nanomedicine (2014) 0.88
Nanomaterials for reducing amyloid cytotoxicity. Adv Mater (2013) 0.87
Nordihydroguaiaretic acid does not disaggregate beta-amyloid(1-40) protofibrils but does inhibit growth arising from direct protofibril association. Mol Pharmacol (2004) 0.87
Effect of Fe(3)O(4) magnetic nanoparticles on lysozyme amyloid aggregation. Nanotechnology (2010) 0.86
Mechanism of impairment of long-term potentiation by amyloid beta is independent of NMDA receptors or voltage-dependent calcium channels in hippocampal CA1 pyramidal neurons. Neurosci Lett (2005) 0.84
Influence of the physiochemical properties of superparamagnetic iron oxide nanoparticles on amyloid β protein fibrillation in solution. ACS Chem Neurosci (2013) 0.82
Surface chemistry but not aspect ratio mediates the biological toxicity of gold nanorods in vitro and in vivo. Sci Rep (2015) 0.81
Poly(acrylic acid)-stabilized colloidal gold nanoparticles: synthesis and properties. Nanotechnology (2010) 0.81
Potential applications of magnetic particles to detect and treat Alzheimer's disease. Nanoscale Res Lett (2014) 0.81
Controlling amyloid-beta peptide(1-42) oligomerization and toxicity by fluorinated nanoparticles. Chembiochem (2010) 0.80
Influence of Au nanoparticles on the aggregation of amyloid-β-(25-35) peptides. Nanoscale (2013) 0.80
Peptide inhibitors of beta-amyloid aggregation. Curr Opin Drug Discov Devel (2007) 0.79
Synthesis and characterization of fluorinated magnetic core-shell nanoparticles for inhibition of insulin amyloid fibril formation. Nanotechnology (2009) 0.79
Uptake of Gold Nanoparticles by Intestinal Epithelial Cells: Impact of Particle Size on Their Absorption, Accumulation, and Toxicity. J Agric Food Chem (2015) 0.79
Comparative study of inhibition at multiple stages of amyloid-beta self-assembly provides mechanistic insight. Mol Pharmacol (2009) 0.78
Physiological temperature has a crucial role in amyloid β in the absence and presence of hydrophobic and hydrophilic nanoparticles. ACS Chem Neurosci (2012) 0.78
Amyloid fibril formation by β-lactoglobulin is inhibited by gold nanoparticles. Int J Biol Macromol (2014) 0.78
Nanomedicine: tiny particles and machines give huge gains. Ann Biomed Eng (2013) 0.77
Randomization of amyloid-β-peptide(1-42) conformation by sulfonated and sulfated nanoparticles reduces aggregation and cytotoxicity. Macromol Biosci (2010) 0.77
Effect of PEGylated superparamagnetic iron oxide nanoparticles (SPIONs) under magnetic field on amyloid beta fibrillation process. Mater Sci Eng C Mater Biol Appl (2015) 0.77
Effect of functionalized magnetic MnFe2O4 nanoparticles on fibrillation of human serum albumin. J Phys Chem B (2014) 0.76
Gold nanoparticles as amyloid-like fibrillogenesis inhibitors. Colloids Surf B Biointerfaces (2013) 0.76
Death and cell cycle progression are differently conditioned by the AgNP size in osteoblast-like cells. Toxicology (2016) 0.76
Attenuation of lysozyme amyloid cytotoxicity by SPION-mediated modulation of amyloid aggregation. Int J Biol Macromol (2015) 0.76